Viewing Study NCT01307592


Ignite Creation Date: 2025-12-24 @ 3:32 PM
Ignite Modification Date: 2026-01-02 @ 4:20 AM
Study NCT ID: NCT01307592
Status: UNKNOWN
Last Update Posted: 2014-01-10
First Post: 2011-03-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Gemcitabine Hydrochloride, Rituximab, Oxaliplatin, and Lenalidomide in Treating Patients With Relapsed or Refractory, Aggressive Non-Hodgkin Lymphoma
Sponsor:
Organization: